Skip to main content
LENZ Therapeutics, Inc. logo

LENZ Therapeutics, Inc. — Investor Relations & Filings

Ticker · LENZ ISIN · US38870X1046 US Manufacturing
Open in API
Filings indexed 329 across all filing types
Latest filing 2023-03-20 Regulatory Filings
Country US United States of America
Listing US LENZ

About LENZ Therapeutics, Inc.

https://lenz-tx.com/

LENZ Therapeutics, Inc. is a late-stage pharmaceutical company focused on developing and commercializing ophthalmic therapies to improve vision. Its primary product is VIZZ™ (aceclidine ophthalmic solution) 1.44%, an FDA-approved eye drop for the treatment of presbyopia, the age-related loss of near vision. VIZZ is the first aceclidine-based therapy for this condition, which affects an estimated 1.8 billion people globally. The product is designed to restore near vision, providing a pharmaceutical alternative to reading glasses for a broad patient population.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and references a press release announcing financial results for the year ended December 31, 2022. The document itself does not contain detailed financial statements or substantive financial data but rather furnishes a press release as an exhibit. The length is 3698 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, a short document that announces or furnishes a press release with financial results but does not contain the full financial report should be classified as a Regulatory Filing (RNS), as it is a current report filing and not the full Annual Report (10-K) or Earnings Release (ER).
2023-03-20 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on the departure and retention agreements of senior management, specifically retention agreements with executive officers. There are no financial statements or quarterly results presented, nor is this an annual report or earnings release. The key content is about management changes and agreements related to executives. Therefore, the document fits best under 'Board/Management Information' (MANG), which covers announcements of changes in the company's board or senior management. The document length is 4690 characters, which is consistent with a detailed announcement rather than a brief notice or a full report. Hence, the classification is MANG with high confidence.
2023-03-16 English
FORM 4 SUBMISSION
Director's Dealing
2023-02-23 English
FORM 4 SUBMISSION
Director's Dealing
2023-02-23 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes a restructuring plan with workforce reduction, severance details for departing officers, and a press release about exploring strategic alternatives and corporate restructuring. There are no financial statements or detailed financial performance data presented, only announcements of corporate actions and management changes. The document is not an annual or quarterly report, nor is it a transcript or earnings release. It primarily announces management changes and restructuring plans, which fits the category of Board/Management Information (MANG). The length (7020 characters) and content confirm it is a substantive filing, not just a brief announcement or certification. Therefore, the best classification is MANG with high confidence.
2023-02-22 English
SC 13G/A
Major Shareholding Notification
2023-02-14 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.